Market share of domestic companies dips in March

Over the years, Korean firms have had to give up the home market to powerful global companies coming in with good medicine and better marketing strategies.

To make matters worse, the performance of Korean pharmaceutical companies have been affected by the government’s policy to abandon “rebates” ― a kind of kickback given by drug companies to pharmacies, clinics and hospitals for buying thei...